Paradox of Psychedelics: From Mind-Bending to Mind-Mending

https://doi.org/10.1556/2054.2019.031
 
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011). Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology, 218(4), 649–665. https://doi.org/10.1007/s00213-011-2358-5
 
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268–283. https://doi.org/10.1007/s00213-006-0457-5
 
Gukasyan, N., Davis, A. K., Barrett, F. S., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., & Griffiths, R. R. (2022). Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Journal of Psychopharmacology, 36(2), 151–158. https://doi.org/10.1177/02698811211073759
 
Holling, H., Benedek, M., Panzierer, L., Jauk, E., & Neubauer, A. C. (2017). Creativity on tap? Effects of alcohol intoxication on creative cognition. Consciousness and Cognition, 56, 128–134. https://doi.org/10.1016/j.concog.2017.06.020
 
Holze, F., Vizeli, P., Ley, L., Müller, F., Dolder, P., Stocker, M., Duthaler, U., Varghese, N., Eckert, A., Borgwardt, S., & Liechti, M. E. (2021). Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology, 46(3), 537–544. https://doi.org/10.1038/s41386-020-00883-6
 
Hutten, N. R., Mason, N. L., Dolder, P. C., Theunissen, E. L., Holze, F., Liechti, M. E., Feilding, A., Ramaekers, J. G., & Kuypers, K. P. (2020). Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study. European Neuropsychopharmacology, 41, 81–91.
 
Katrin H. Preller, Preller, K. H., Pokorny, T., Hock, A., Kraehenmann, R., Stämpfli, P., Seifritz, E., Scheidegger, M., & Vollenweider, F. X. (2016). Effects of serotonin 2A/1A receptor stimulation on social exclusion processing. Proceedings of the National Academy of Sciences of the United States of America, 113(18), 5119–5124. https://doi.org/10.1073/pnas.1524187113
 
Maria Semkovska, Semkovska, M., & McLoughlin, D. M. (2010). Objective Cognitive Performance Associated with Electroconvulsive Therapy for Depression: A Systematic Review and Meta-Analysis. Biological Psychiatry, 68(6), 568–577. https://doi.org/10.1016/j.biopsych.2010.06.009
 
McCulloch, D. E.-W., Madsen, M. B., Madsen, M. K., Stenbæk, D. S., Kristiansen, S., Ozenne, B., Jensen, P. S., Jensen, P. S., Knudsen, G. M., & Fisher, P. M. (2021). Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals: Journal of Psychopharmacology, 2698811211026454. https://doi.org/10.1177/02698811211026454
 
Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264–355. https://doi.org/10.1124/pr.115.011478
 
Pokorny, T., Duerler, P., Seifritz, E., Vollenweider, F. X., & Preller, K. H. (2020). LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making. Psychological Medicine, 50(13), 2255–2264. https://doi.org/10.1017/S0033291719002393
 
Quednow, B. B., Kometer, M., Geyer, M. A., & Vollenweider, F. X. (2012). Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers. Neuropsychopharmacology, 37(3), 630–640. https://doi.org/10.1038/npp.2011.228
 
Swanson, L. R. (2018). Unifying Theories of Psychedelic Drug Effects. Frontiers in Pharmacology, 9, 172–172.

Autore/i dell'articolo

Ritratto di Ceyda Sayalı
Ceyda Sayalı

Ceyda Sayalı è una neuroscienziata cognitiva che studia i meccanismi neurocognitivi alla base degli effetti immediati e a...more

Articolo in pdf

Newsletter

Keep me updated about new In-Mind articles, blog entries and more.

Facebook